Strategic Report Corporate Governance Financial Statements Additional Information Trade Marks AstraZeneca, the AstraZeneca logotype and the AstraZeneca symbol are all trade marks of the Group.
The following brand names which appear in italics in this Annual Report are trade marks of the Group: Trade mark Accolate Entocort Nolvadex Symbicort Turbuhaler Arimidex Farxiga Onglyza Symlin 1 Atacand Faslodex Oxis Turbuhaler Synagis Atacand Plus Fluenz Plendil Tenormin Axanum FluMist Prilosec Toprol-XL Bricanyl Forxiga Pulmicort Turbuhaler Brilinta Iressa Pulmicort Respules Vimovo Brilique Kombiglyze Pulmicort Turbuhaler Xigduo Bydureon Kombiglyze XR Rhinocort Xylocaine Byetta Komboglyze Seloken Zestril Caprelsa Losec Seroquel Zoladex Casodex Meronem Seroquel IR Zomig Crestor Merrem Seroquel XR Diprivan Naropin Symbicort EMLA Nexium Symbicort SMART 1 AstraZeneca owns this trade mark in the US only.
Abbott owns it in the rest of the world.
The following brand names which appear in italics in this Annual Report are trade marks licensed to the Group by the entities set out below: Trade mark Owner Cubicin Cubist Pharmaceuticals, Inc. Epanova Chrysalis Pharma AG Zinforo Forest Laboratories, Inc.
The following brand names which appear in italics throughout this Annual Report are not owned by or licensed to the Group and are owned by the entities set out below: Trade mark Owner Lipitor Pfizer Ireland Pharmaceuticals messenger RNA Therapeutics Moderna Therapeutics, Inc. AstraZeneca Annual Report and Form 20-F Information 2013 231
